Login to Your Account

Taking on Lipids AND Cholesterol

Can Catabasis’ SMART Drug Help it to Play Catch Up?

By Brian Orelli
Contributing Writer

Tuesday, September 3, 2013

Although the market to treat high cholesterol and high triglycerides is crowded with drugs, with plenty more in the later stages of clinical development, Catabasis Pharmaceuticals Inc. execs said the firm has a shot to compete despite its late start. The secret weapon: a two-pronged drug using its SMART-linker technology that can be delivered orally.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription